Kevin Deane, MD, PhD
Disclosures: Consulting Fee-Research (kits) and consulting-Inova Diagnostics|Consulting Fee-PI and consulting-Janssen Research and Development|Consulting Fee-Consulting-Microdrop, LLC|Consulting Fee-Consulting-Bristol-Myers Squibb|Consulting fees and honorarium-Consulting fees, honorarium for being invited speaker at symposium-ThermoFisher|Honoraria-Written educational material-MedScape

Kevin Deane, MD/PhD is a Rheumatologist and Associate Professor of Medicine at the University of Colorado Denver Anschutz Medical Campus. His research interests are in studying the natural history of rheumatoid arthritis (RA) development, and RA prevention. He is the principal investigator of ‘StopRA’, an ongoing NIH-sponsored prevention trial in RA that is testing the efficacy and safety of hydroxychloroquine to prevent or delay the onset of RA in high-risk individuals: NCT02603146.